LaunchBio presents: Invest In Cures

LaunchBio, along with BioLabs North Carolina, the North Carolina Biotechnology Center, NCBIO and the Council for Entrepreneurial Development, are welcoming investment professionals from disease foundations to discuss their investment philosophies, explain their fund and deal structures, and describe how they are using deep scientific knowledge to validate early-stage technologies and syndicate with other investors. We encourage all who are interested in learning about this emerging community of investors to join at the North Carolina Biotechnology Center.

Speakers

Mark Allegretta, Ph.D., associate VP, Commercial Research, National Multiple Sclerosis Society
Jonathan Behr, Ph.D., managing director, T1D Fund, Juvenile Diabetes Research Foundation
Robert Crutchfield, managing director, BrightEdge Ventures, American Cancer Society
Gerard Honig, Ph.D., manager, Translational Research, IBD Ventures, Crohn’s and Colitis Foundation
Debra Miller, president & CEO, CureDuchenne Ventures
Chris Penland, Ph.D., vice president, Biopharma Programs, Cystic Fibrosis Foundation
Barbara Tate, Ph.D., venture partner, Dementia Discovery Fund 
Ben Yerxa, Ph.D., CEO, Retinal Degeneration Fund, Foundation Fighting Blindness

Moderators

Christy Shaffer, Ph.D., partner, Hatteras Venture Partners 
William N. Wofford, attorney, Hutchison PLLC